Category Archives: Uncategorized

[Source: Research & Innovation] Implementing the Human Resources Strategy to comply with art. 32 of the H2020 multi-beneficiary grant agreement

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-LC-SC3-2018-2019-2020Pillar: Societal ChallengesOpening Date: Deadline: Thu, 5 Apr 2018 17:00:00 (Brussels local time)Modification Date: Wed, 1 Aug

Verana Health, a company that analyzes electronic health record data for insights useful in developing new drugs and medical devices,

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-FETOPEN-2018-2020Pillar: Excellent ScienceOpening Date: Deadline: Wed, 16 May 2018 17:00:00 (Brussels local time)Modification Date: Tue, 31 Jul

On July 25, when the European Court of Justice (ECJ), the European Union’s highest court, issued its ruling on directed

Orexigen Therapeutics went bankrupt trying to turn its weight loss pill, Contrave, into a commercial success. Now Pernix Therapeutics will

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: REC-AG-2018Pillar: REC Programme 2014-2020Opening Date: Deadline: Thu, 11 Oct 2018 17:00:00 (Brussels local time)Modification Date: Mon, 30

This week, Representative Comstock introduced the Study of Underrepresented Classes Chasing Engineering and Science Success Act of 2018, also known

Sean Harper, executive vice president of research and development at Amgen (NASDAQ: AMGN), is retiring in order to pursue work

[Source: http://ec.europa.eu/health/ageing/innovation/index_en.htm] Identifier: H2020-SC1-BHC-2018-2020Pillar: Societal ChallengesOpening Date: Deadline: Tue, 6 Feb 2018 17:00:00 (Brussels local time)Modification Date: Fri, 27 Jul